NME
Notis-McConarty Edward Portfolio holdings
AUM
$205M
This Quarter Return
+5.32%
1 Year Return
+14.8%
3 Year Return
+72.99%
5 Year Return
+119.96%
10 Year Return
+295.3%
AUM
$146M
AUM Growth
+$146M
(+3%)
Cap. Flow
-$1.43M
Cap. Flow
% of AUM
-0.98%
Top 10 Holdings %
Top 10 Hldgs %
30.9%
Holding
120
New
4
Increased
18
Reduced
18
Closed
5
Top Buys
| 1 |
CDK
CDK Global, Inc.
CDK
|
$655K |
| 2 |
Xylem
XYL
|
$283K |
| 3 |
Helmerich & Payne
HP
|
$243K |
| 4 |
RTX Corp
RTX
|
$236K |
| 5 |
Texas Instruments
TXN
|
$219K |
Top Sells
| 1 |
GSK
GSK
|
$1.8M |
| 2 |
Exxon Mobil
XOM
|
$700K |
| 3 |
Qualcomm
QCOM
|
$330K |
| 4 |
Labcorp
LH
|
$278K |
| 5 |
Oceaneering
OII
|
$261K |
Sector Composition
| 1 | Healthcare | 22.96% |
| 2 | Technology | 21.99% |
| 3 | Industrials | 17.97% |
| 4 | Energy | 9.95% |
| 5 | Consumer Staples | 9.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Cigna
CI
$80.9B
| $196K | 0.13% |
1,900
| – | – |
|
102
Adobe
ADBE
$146B
| $173K | 0.12% |
2,380
| – | – |
|
103
Ovintiv
OVV
$10.8B
| $169K | 0.12% |
12,200
| – | – |
|
104
General Mills
GIS
$26.4B
| $160K | 0.11% |
3,000
| – | – |
|
105
McKesson
MCK
$86.3B
| $156K | 0.11% |
750
| – | – |
|
|
ALXN
106
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $139K | 0.1% |
750
| – | – |
|
107
Starbucks
SBUX
$99.3B
| $135K | 0.09% |
1,650
| – | – |
|
108
Boston Properties
BXP
$11.4B
| $129K | 0.09% |
1,000
| – | – |
|
109
Novo Nordisk
NVO
$250B
| $106K | 0.07% |
2,500
| – | – |
|
110
Dover
DOV
$24B
| $72K | 0.05% |
1,000
| – | – |
|
|
111
GSK
GSK
$78.7B
| – | – |
-39,170
| Closed | -$1.8M |
|
|
112
Labcorp
LH
$23B
| – | – |
-2,730
| Closed | -$278K |
|
|
113
Oceaneering
OII
$2.42B
| – | – |
-4,000
| Closed | -$261K |
|
|
SDRL
114
DELISTED
Seadrill Limited Common Stock
SDRL
| – | – |
-8,100
| Closed | -$217K |
|
|
KMP
115
DELISTED
KINDER MORGAN ENER PNTRS L.P.
KMP
| – | – |
-1,000
| Closed | -$93K |
|